About Kelly Morgan

Kelly joined Ring Therapeutics as SVP, Head of Legal in September 2024. Prior to joining Ring, Kelly was SVP, Head of Legal at Arbor Biotechnologies where she was responsible for overseeing and managing the legal function including IP, licensing, corporate governance and HR. Prior to Arbor, Kelly served as IP counsel at Flagship for several years, developing legal structure of funding and management of multiple portfolio biotechnology companies, including Ring Therapeutics. Kelly holds a JD from Suffolk University, a PhD from the University of Michigan. Kelly also conducted post doctoral research at the Howard Hughes Medical Institute of the Harvard Medical School.